Small W, Silva C, Johnson R, Betti V, Nguyen A, Todd L
Front Psychiatry. 2025; 15:1535780.
PMID: 39911558
PMC: 11794492.
DOI: 10.3389/fpsyt.2024.1535780.
Pintos-Rodriguez S, Visos-Varela I, Rodriguez-Fernandez A, Zapata-Cachafeiro M, Pineiro-Lamas M, Herdeiro M
Int J Neuropsychopharmacol. 2024; 27(4).
PMID: 38600711
PMC: 11059787.
DOI: 10.1093/ijnp/pyae020.
Almeida O, Page A, Sanfilippo F, Preen D, Etherton-Beer C
Aust N Z J Psychiatry. 2023; 58(2):183-186.
PMID: 38084609
PMC: 10838474.
DOI: 10.1177/00048674231217700.
Molero P, Reina G, Blom J, Martinez-Gonzalez M, Reinken A, de Kloet E
Epidemiol Psychiatr Sci. 2023; 32:e61.
PMID: 37859501
PMC: 10594644.
DOI: 10.1017/S2045796023000719.
Ryu S, Kang H, Jung H, Yun H, Kang S, Kim T
Front Psychiatry. 2023; 14:1195103.
PMID: 37260761
PMC: 10228693.
DOI: 10.3389/fpsyt.2023.1195103.
Serious mental illness and in-hospital mortality among hospitalized patients with acute COVID-19: A large-database analysis in Japan.
Tokuda Y, Barnett P, Sanji S, Takaizumi Y, Tomono M, Tokuda H
Gen Hosp Psychiatry. 2023; 82:1-6.
PMID: 36868102
PMC: 9894824.
DOI: 10.1016/j.genhosppsych.2023.01.014.
Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis.
Fico G, Isayeva U, De Prisco M, Oliva V, Sole B, Montejo L
Eur Neuropsychopharmacol. 2022; 66:30-44.
PMID: 36399837
PMC: 9581805.
DOI: 10.1016/j.euroneuro.2022.10.004.
Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients.
Schoning V, Hammann F
Pharmaceutics. 2022; 14(9).
PMID: 36145576
PMC: 9504398.
DOI: 10.3390/pharmaceutics14091828.
Joint European policy on the COVID-19 risks for people with mental disorders: An umbrella review and evidence- and consensus-based recommendations for mental and public health.
Vai B, Mazza M, Marisa C, Beezhold J, Karkkainen H, Saunders J
Eur Psychiatry. 2022; 65(1):e47.
PMID: 35971656
PMC: 9486830.
DOI: 10.1192/j.eurpsy.2022.2307.
Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.
Nemani K, Williams S, Olfson M, Leckman-Westin E, Finnerty M, Kammer J
JAMA Netw Open. 2022; 5(5):e2210743.
PMID: 35522282
PMC: 9077485.
DOI: 10.1001/jamanetworkopen.2022.10743.
Clozapine and COVID-19 Vaccination: Effects on blood levels and leukocytes. An observational cohort study.
Veerman S, Moscou T, Bogers J, Cohen D, Schulte P
Acta Psychiatr Scand. 2022; 146(2):168-178.
PMID: 35322409
PMC: 9111344.
DOI: 10.1111/acps.13428.
Association between serum lithium level and incidence of COVID-19 infection.
De Picker L, Leboyer M, Geddes J, Morrens M, Harrison P, Taquet M
Br J Psychiatry. 2022; 221(1):425-427.
PMID: 35318909
PMC: 7612897.
DOI: 10.1192/bjp.2022.42.
COVID-19-Related Mortality Risk in People With Severe Mental Illness: A Systematic and Critical Review.
De Hert M, Mazereel V, Stroobants M, De Picker L, Van Assche K, Detraux J
Front Psychiatry. 2022; 12:798554.
PMID: 35095612
PMC: 8793909.
DOI: 10.3389/fpsyt.2021.798554.
Antipsychotics and COVID-19: the debate goes on - Authors' reply.
De Picker L, Mazza M, Vai B
Lancet Psychiatry. 2021; 8(12):1030-1031.
PMID: 34801117
PMC: 8601685.
DOI: 10.1016/S2215-0366(21)00428-4.
